The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

28 Feb 2019 10:35

RNS Number : 4338R
Instem plc
28 February 2019
 

Instem plc("Instem" or the "Company")

Issue of Equity and Total Voting Rights

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that, following the exercise of share options, 93,713 new ordinary shares of 10p each in the Company ("Ordinary Shares") have been issued.

Application will be made to the London Stock Exchange for the admission of the 93,713 new Ordinary Shares to trading on AIM ("New Ordinary Shares"). Admission is expected to take place at 8.00 a.m. on 6 March 2019.

Total Voting Rights

Following the issue and allotment of the above New Ordinary Shares, the Company's issued share capital will comprise 16,246,983 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company will be 16,246,983.

The figure of 16,246,983 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

For further information, please contact:

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

 

Nigel Goldsmith, CFO

 

 

 

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Richard Lindley, Corporate Finance

 

Rachel Hayes, Corporate Broking

 

 

 

 

 

 

 

Walbrook Financial PR

 

Paul Cornelius

+44 (0) 20 7933 8780

Sam Allen

instem@walbrookpr.com

Nick Rome

 

 

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

 Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAEAPADANEFF
Date   Source Headline
22nd Jan 200812:11 pmRNSAcquisition
22nd Jan 200812:00 pmRNSDisposal
21st Dec 20071:22 pmRNSChange of Year End
22nd Oct 20075:57 pmRNSNotification of Shares
10th Oct 20075:29 pmRNSTrading Statement
27th Sep 200712:43 pmRNSNotification of Shares
7th Sep 20071:25 pmRNSNotification of Shares
31st Aug 20075:10 pmRNSOffer Update
31st Aug 20071:53 pmRNSTotal Voting Rights
28th Aug 20074:58 pmRNSAIM Rule 26
22nd Aug 20077:00 amRNSOffer Update
20th Aug 20072:37 pmRNSInterim Results
7th Aug 20075:41 pmRNSOffer Update
7th Aug 20075:29 pmRNSHolding(s) in Company
2nd Aug 20075:43 pmRNSExercise of options
31st Jul 20074:55 pmRNSExercise of Options
27th Jul 20078:00 amRNSIssue of Equity
24th Jul 20075:09 pmRNSOffer Update
24th Jul 20072:49 pmRNSDirector/PDMR Shareholding
24th Jul 20072:47 pmRNSDirector/PDMR Shareholding
24th Jul 20072:46 pmRNSDirector/PDMR Shareholding
24th Jul 20072:45 pmRNSDirector/PDMR Shareholding
24th Jul 20072:42 pmRNSDirector/PDMR Shareholding
23rd Jul 20073:41 pmRNSHolding(s) in Company
23rd Jul 20071:30 pmRNSAGM Statement
20th Jul 200712:08 pmRNSHolding(s) in Company
10th Jul 20072:13 pmBUSRule 8.3 - International Nuclear Solutions
9th Jul 20073:03 pmBUSRule 8.3 - International Nuclear Solutions
9th Jul 200712:10 pmRNSOffer unconditional
9th Jul 20079:33 amRNSInt Nuclear Solutions
6th Jul 20073:09 pmBUSRule 8.3 - International Nuclear Solutions
5th Jul 20071:51 pmBUSRule 8.3 - International Nuclear Solutions
4th Jul 200712:38 pmBUSRule 8.3 - International Nuclear Solutions
3rd Jul 20072:25 pmBUSRule 8.3 - International Nuclear Solutions
29th Jun 20073:05 pmRNSHolding(s) in Company
28th Jun 200711:44 amRNSHolding(s) in Company
28th Jun 20079:24 amRNSRule 8.1- Intnl Nuclear Sol.
27th Jun 20073:34 pmBUSRule 8.3 - International Nuclear Solutions
25th Jun 20073:18 pmRNSRule 8.1- (Intl Nuclear Sol)
25th Jun 20079:01 amRNSHolding(s) in Company
21st Jun 20072:52 pmBUSRule 8.3 - International Nuclear Solution
21st Jun 20072:34 pmRNSRule 8.3- Int'l Nuclear Sol
20th Jun 20073:19 pmBUSRule 8.3 - INTERNATIONAL NUCLEAR SOLUTIONS
20th Jun 20071:35 pmRNSRule 8.3- Int'l Nuclear Sol.
20th Jun 200710:16 amRNSRule 8.3- Intl Nuclear Sols
20th Jun 200710:02 amRNSRule 8.1- Intl Nuclear Sol
19th Jun 20077:03 amRNSOffer for INS
15th Jun 200711:53 amRNSRule 8.3- Intnl Nuclear
12th Jun 200711:08 amRNSRule 8.3- Intnl Nuclear Sol.
29th May 20073:18 pmBUSRule 8.3 - International Nuclear Solution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.